Uppsala, Sweden

Martin Henriksson

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 12.6

ph-index = 3

Forward Citations = 30(Granted Patents)


Location History:

  • Stockholm, SE (2007 - 2013)
  • Uppsala, SE (2007 - 2014)
  • Bromma, SE (2022)

Company Filing History:


Years Active: 2007-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Inventor Spotlight: Martin Henriksson

Introduction

Martin Henriksson is an accomplished inventor hailing from Uppsala, Sweden. With a remarkable portfolio of seven patents, Henriksson has significantly contributed to the field of pharmaceutical innovations, particularly focusing on therapeutic compounds for various diseases.

Latest Patents

Henriksson's latest inventions include the development of 2,6-diamino-3,4-dihydropyrimidin-4-one derivatives. These compounds, including their pharmaceutically acceptable salts, have shown promise in treating serious medical conditions such as cancers, inflammation, autoimmune diseases, and graft-versus-host diseases, especially in transplantation patients. Additionally, he has developed pharmaceutical compositions containing these compounds and methodologies for their synthesis.

Career Highlights

Throughout his career, Martin has made a significant mark by working with prominent companies such as Amgen Inc. and Biovitrum AB. His tenure at these organizations has allowed him to collaborate on cutting-edge research and development projects aimed at advancing therapeutic options in medicine.

Collaborations

Henriksson has worked alongside notable peers, including Evert Homan and Meredith Williams. Their collaborations have contributed to enhancing the quality of research and the innovative processes within the pharmaceutical sector.

Conclusion

Martin Henriksson's contributions to the field of pharmacology through his patents and collaborations illustrate his commitment to advancing medical therapies. His work not only impacts the academic and scientific communities but also holds the potential to improve patient outcomes significantly. As he continues to innovate, the medical landscape may see further advancements stemming from his groundbreaking research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…